News

ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created ...
ALX Oncology receives IND clearance from FDA for ALX2004
ALX Oncology (ALXO) announced receipt of U.S. Food and Drug Administration clearance for the Investigational New Drug application for ALX2004, ...
Targeted Oncology1d
FDA Advances ALX2004 to Phase 1 Trials in EGFR+ Solid Tumors
The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for ...
Hosted on MSN19d
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
The price trend for ALX Oncology Holdings Inc. (ALXO) has been bearish lately and the stock has lost 19.6% over the past week. However, the formation of a hammer chart pattern in its last trading ...
Yahoo Finance4d
Alexander's, Inc. (ALX)
NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025. ALX, AVGO and BNPQY made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 3 ...
SFGate1mon
Bay Area biotech firm once worth more than $3B lays off 30% of staff
ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff. ALX shared the news in a ...
BioWorld2d
FDA clears ALX Oncology’s IND for ALX-2004
ALX Oncology Holdings Inc. has received FDA clearance for the IND application for ALX-2004, the company’s potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of ...
Business and Financial Times on MSN2d
We’re committed to bridging digital literacy skills gap – ALX Country Manager
ALX Ghana has reaffirmed its commitment to helping bridge the digital literacy gap in the country, with an ambitious plan ...